BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21029243)

  • 1. A quantitative study of the pathological changes in the cerebellum in 15 cases of variant Creutzfeldt-Jakob disease (vCJD).
    Armstrong RA; Ironside JW; Lantos PL; Cairns NJ
    Neuropathol Appl Neurobiol; 2009 Feb; 35(1):36-45. PubMed ID: 19187059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal change prion retinopathy: Morphometric comparison of retinal and brain prion deposits in Creutzfeldt-Jakob disease.
    Goodwill VS; Dryden I; Choi J; De Lillo C; Soldau K; Llibre-Guerra J; Sanchez H; Sigurdson CJ; Lin JH
    Exp Eye Res; 2022 Sep; 222():109172. PubMed ID: 35803332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An antibody to the aggregated synthetic prion protein peptide (PrP106-126) selectively recognizes disease-associated prion protein (PrP) from human brain specimens.
    Jones M; Wight D; McLoughlin V; Norrby K; Ironside JW; Connolly JG; Farquhar CF; MacGregor IR; Head MW
    Brain Pathol; 2009 Apr; 19(2):293-302. PubMed ID: 18507665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of soluble and insoluble PrP oligomers in the normal human brain.
    Xiao X; Yuan J; Zou WQ
    J Vis Exp; 2012 Oct; (68):. PubMed ID: 23070047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain-specific prion-protein conformation determined by metal ions.
    Wadsworth JD; Hill AF; Joiner S; Jackson GS; Clarke AR; Collinge J
    Nat Cell Biol; 1999 May; 1(1):55-9. PubMed ID: 10559865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-existence of PrP
    Cali I; Puoti G; Smucny J; Curtiss PM; Cracco L; Kitamoto T; Occhipinti R; Cohen ML; Appleby BS; Gambetti P
    Sci Rep; 2020 Jan; 10(1):1503. PubMed ID: 32001774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of human prion disease.
    Safar JG; Geschwind MD; Deering C; Didorenko S; Sattavat M; Sanchez H; Serban A; Vey M; Baron H; Giles K; Miller BL; Dearmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3501-6. PubMed ID: 15741275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular pathology of CJD: old and new variants.
    Jackson GS; Collinge J
    Mol Pathol; 2001 Dec; 54(6):393-9. PubMed ID: 11724914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC.
    Hosszu LL; Jackson GS; Trevitt CR; Jones S; Batchelor M; Bhelt D; Prodromidou K; Clarke AR; Waltho JP; Collinge J
    J Biol Chem; 2004 Jul; 279(27):28515-21. PubMed ID: 15123682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial respiratory chain deficiency correlates with the severity of neuropathology in sporadic Creutzfeldt-Jakob disease.
    Flønes IH; Ricken G; Klotz S; Lang A; Ströbel T; Dölle C; Kovacs GG; Tzoulis C
    Acta Neuropathol Commun; 2020 Apr; 8(1):50. PubMed ID: 32299489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional genomics screen identifies proteostasis targets that modulate prion protein (PrP) stability.
    Abrams J; Arhar T; Mok SA; Taylor IR; Kampmann M; Gestwicki JE
    Cell Stress Chaperones; 2021 Mar; 26(2):443-452. PubMed ID: 33547632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Light on Prions: Putative Role of PrP
    Chrobak AA; Pańczyszyn-Trzewik P; Król P; Pawelec-Bąk M; Dudek D; Siwek M
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of prion protein (PrP(C)) in the megakaryocyte lineage.
    Starke R; Harrison P; Mackie I; Wang G; Erusalimsky JD; Gale R; Massé JM; Cramer E; Pizzey A; Biggerstaff J; Machin S
    J Thromb Haemost; 2005 Jun; 3(6):1266-73. PubMed ID: 15946217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathological changes in striate and extrastriate visual cortex in variant Creutzfeldt-Jakob disease (vCJD).
    Armstrong RA
    Clin Ophthalmol; 2007 Jun; 1(2):119-25. PubMed ID: 19668500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An In Vivo
    Iaccarino L; Moresco RM; Presotto L; Bugiani O; Iannaccone S; Giaccone G; Tagliavini F; Perani D
    Mol Neurobiol; 2018 Apr; 55(4):2856-2868. PubMed ID: 28455699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant CJD. 18 years of research and surveillance.
    Diack AB; Head MW; McCutcheon S; Boyle A; Knight R; Ironside JW; Manson JC; Will RG
    Prion; 2014; 8(4):286-95. PubMed ID: 25495404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotoxicity of prion peptides mimicking the central domain of the cellular prion protein.
    Vilches S; Vergara C; Nicolás O; Sanclimens G; Merino S; Varón S; Acosta GA; Albericio F; Royo M; Del Río JA; Gavín R
    PLoS One; 2013; 8(8):e70881. PubMed ID: 23940658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of polydispersed prion protein and characteristic pathology in the thalamus in variant Creutzfeldt-Jakob disease: implication of small oligomeric species.
    Choi YP; Gröner A; Ironside JW; Head MW
    Brain Pathol; 2011 May; 21(3):298-307. PubMed ID: 21029243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002.
    Head MW; Bunn TJ; Bishop MT; McLoughlin V; Lowrie S; McKimmie CS; Williams MC; McCardle L; MacKenzie J; Knight R; Will RG; Ironside JW
    Ann Neurol; 2004 Jun; 55(6):851-9. PubMed ID: 15174020
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.